BEMORDA PASTKI SIYDIK YO‘LLARI OBSTUKSIYASINI YO‘QOTISH NUQTAI NAZARI BILAN TASHRIXLARNI SAMARADORLIGINI BAXOLASH
Abstract
Oxirgi yillarda butun jaxonda insonlarning o‘rtacha umr ko‘rish koefitsenti oshib borayotganligi ma’lum. Masalan, dunyo axolisining o‘rtacha 11,8% qismi 60 yoshdan oshgan erkaklar bo‘lsa oxirgi 20 yil ichida ushbu ko‘rsatkich 22 %gacha ko‘tarilganini ko‘rishimiz mumkin. Shuni xisobga oladigan bo‘lsak, prostata bezi xavfsiz giperplaziyasi (PBXG) bilan og‘riydigan erkaklar qatlami xam o‘z-o‘zidan ko‘payadi. Bu esa PBXG jarroxlik davolash optimal metodlarini yaratish uchun qo‘pgina ilmiy amaliy izlanishlar uchun turtki bo‘ladi
References
Шадманов М.А., Садикова Д.И. Профилактика воспаления после операции доброкачественной гиперплазии предстательной железы// Журнал «Экономика и социум», Москва, 2023, 5(108), с.91-94
Buzelin J.M., Delauche-Cavallier M.C. et al. Clinical uroselectivity: evidence from patients treated with slow release alfusozin for symptomatic benighn prostatic obstruction// Br J Urol. 2017; 79: 898-906.
Djavan В. Мeta-analysis on the efficacy and tolerability of a 1- adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of the benign prostatic obstruction// Eur. Urol. - 2019. - Vol. 36. - P. 11-13.
Etreby M.F., Habenicht U.F. The function and the role of aromatase inhibitors in the treatment of BPH// In Benign prostatic hyperplasia. – Wiley Liss, 2020. -P.209-230.
Mahler C.Y., Peeling W.B. The normal prostate. In Altwein (edt) with benign prostatic hyperplasia a diagnosis and treatment primer// Merk and Co.Inc. - 2022. - P. 210-213
